Bioenergetics and Metabolism
ATP and group transfer, glycolysis, TCA cycle, oxidative phosphorylation, and metabolism of sugars, lipids, amino acids and nucleotides for CSIR NET.
- 25 min
On this page · 19 sections
- Prerequisites
- The Hook: Mitochondria in an Oxygen Electrode
- Bioenergetics: ATP, Group Transfer and Coupling
- Glycolysis
- Gluconeogenesis
- The Pentose Phosphate Pathway
- Glycogen Metabolism
- The Citric Acid (TCA, Krebs) Cycle
- Oxidative Phosphorylation
- Lipid Metabolism
- Amino-Acid Metabolism
- Nucleotide Metabolism
- Memory Tricks
- Don’t Confuse
- Common Mistakes
- Practice
- Quick Revision Table
- Key Takeaways
- What’s Next
Prerequisites
- Chemical Bonds, Stabilising Interactions and Biophysical Chemistry — ΔG = ΔG°’ + RT ln Q and ΔG°’ = −nFΔE°’ are used on every line here.
- Enzymes: Catalysis, Kinetics and Regulation — allostery, phosphorylation and isozymes are how pathways are controlled.
- Carbohydrates, Lipids, Nucleic Acids and Vitamins — the structures being made and broken, and the vitamin-derived coenzymes.
The Hook: Mitochondria in an Oxygen Electrode
How CSIR NET asks it. Part B: enzyme–step pairs, regulatory enzymes, inhibitor–site pairs, ATP yields, coenzymes, inborn errors. Part C: ΔG at cellular concentrations, ΔG°’ from redox potentials, oxygen-electrode traces, isotope-labelling fates, ATP accounting for unusual fuels, and “which statements are correct” about regulation.
Bioenergetics: ATP, Group Transfer and Coupling
Why ATP hydrolysis releases so much free energy
ATP → ADP + Pᵢ has ΔG°’ = −30.5 kJ/mol. The reasons:
- Charge repulsion between the negatively charged phosphates is relieved.
- Resonance stabilisation of Pᵢ is greater than that of the bound phosphate.
- ADP³⁻ immediately ionises, releasing H⁺ into a medium at pH 7.
- The products are better solvated than ATP.
In cells, [ATP]/[ADP][Pᵢ] is kept far from equilibrium, so the actual ΔG (the phosphorylation potential, ΔGp) is much more negative, around −50 to −65 kJ/mol. Mg²⁺–ATP is the true substrate of most kinases.
Group transfer potentials
The “high-energy” label refers to a large negative ΔG°’ of hydrolysis, not to a special bond. Rows are in order of ΔG°’; a phosphoryl donor higher in the table can phosphorylate the hydrolysis product of one lower down under standard conditions.
| Compound | ΔG°’ of hydrolysis (kJ/mol) |
|---|---|
| Phosphoenolpyruvate (PEP) | −61.9 |
| 1,3-Bisphosphoglycerate | −49.3 |
| ATP → AMP + PPᵢ | −45.6 |
| Phosphocreatine | −43.0 |
| ADP → AMP + Pᵢ | −32.8 |
| Acetyl-CoA (thioester) | −31.4 |
| ATP → ADP + Pᵢ | −30.5 |
| PPᵢ → 2 Pᵢ | −19.2 |
| Glucose 1-phosphate | −20.9 |
| Fructose 6-phosphate | −15.9 |
| Glucose 6-phosphate | −13.8 |
| Glycerol 3-phosphate | −9.2 |
(Values from Lehninger.) ATP sits in the middle, so it can accept phosphoryl groups from PEP and 1,3-BPG (substrate-level phosphorylation) and donate them to glucose and glycerol. PEP is so high because its product, the enol of pyruvate, tautomerises to the much more stable keto form. Phosphocreatine is the muscle’s ATP buffer (creatine kinase).
Coupled reactions
Because free energies are additive, an unfavourable reaction is driven by coupling to a favourable one through a shared intermediate (here, ATP’s phosphoryl group goes onto glucose directly):
$$\begin{array}{lr} \text{Glucose} + \mathrm{P_i} \to \text{glucose 6-phosphate} & \Delta G^{\circ\prime} = +13.8\ \mathrm{kJ/mol}\\ \mathrm{ATP} + \mathrm{H_2O} \to \mathrm{ADP} + \mathrm{P_i} & \Delta G^{\circ\prime} = -30.5\ \mathrm{kJ/mol}\\ \hline \text{Glucose} + \mathrm{ATP} \to \text{glucose 6-phosphate} + \mathrm{ADP} & \Delta G^{\circ\prime} = -16.7\ \mathrm{kJ/mol} \end{array}$$Many biosynthetic reactions split ATP to AMP + PPᵢ, and inorganic pyrophosphatase then hydrolyses PPᵢ, pulling the reaction forward (aminoacyl-tRNA synthesis, fatty acyl-CoA synthesis, DNA and RNA polymerisation).
Group transfer in metabolism is not only phosphoryl: ATP can transfer pyrophosphoryl (PRPP synthesis), adenylyl (fatty acid activation, glutamine synthetase regulation) or adenosyl (S-adenosylmethionine) groups. Other carriers: acetyl-CoA (acyl groups), NADH/NADPH/FADH₂ (electrons), UDP-glucose (glucose), SAM (methyl), biotin (CO₂), THF (one-carbon units).
Redox energetics
| Half-reaction (written as reduction) | E°’ (V) |
|---|---|
| ½O₂ + 2H⁺ + 2e⁻ → H₂O | +0.816 |
| Cytochrome c (Fe³⁺) + e⁻ → Fe²⁺ | +0.254 |
| Ubiquinone + 2H⁺ + 2e⁻ → ubiquinol | +0.045 |
| Fumarate + 2H⁺ + 2e⁻ → succinate | +0.031 |
| Pyruvate + 2H⁺ + 2e⁻ → lactate | −0.185 |
| NAD⁺ + H⁺ + 2e⁻ → NADH | −0.320 |
For NADH → O₂: \(\Delta E^{\circ\prime} = 0.816 - (-0.320) = 1.136\) V, so \(\Delta G^{\circ\prime} = -2(96.485)(1.136) = -219\) kJ/mol, enough in principle for several ATP.
NADH vs NADPH: NAD⁺/NADH is kept mostly oxidised (catabolism needs an oxidant); NADP⁺/NADPH is kept mostly reduced (biosynthesis needs a reductant).
Glycolysis
Ten cytosolic reactions convert one glucose into two pyruvate.
graph TD
G["Glucose"] -->|"1 Hexokinase, ATP used"| G6P["Glucose 6-P"]
G6P -->|"2 Phosphohexose isomerase"| F6P["Fructose 6-P"]
F6P -->|"3 PFK-1, ATP used, committed step"| FBP["Fructose 1,6-bisP"]
FBP -->|"4 Aldolase"| T["DHAP + Glyceraldehyde 3-P"]
T -->|"5 Triose phosphate isomerase"| GAP["2 x Glyceraldehyde 3-P"]
GAP -->|"6 GAPDH, NADH made, Pi added"| BPG["2 x 1,3-Bisphosphoglycerate"]
BPG -->|"7 Phosphoglycerate kinase, ATP made"| PG3["2 x 3-Phosphoglycerate"]
PG3 -->|"8 Phosphoglycerate mutase"| PG2["2 x 2-Phosphoglycerate"]
PG2 -->|"9 Enolase, H2O lost"| PEP["2 x PEP"]
PEP -->|"10 Pyruvate kinase, ATP made"| PYR["2 x Pyruvate"]Net: Glucose + 2NAD⁺ + 2ADP + 2Pᵢ → 2 pyruvate + 2NADH + 2H⁺ + 2ATP + 2H₂O.
- Preparatory phase (steps 1–5) invests 2 ATP; payoff phase (6–10) occurs twice per glucose and yields 4 ATP and 2 NADH.
- Substrate-level phosphorylation at steps 7 (phosphoglycerate kinase) and 10 (pyruvate kinase).
- Irreversible, regulated steps: hexokinase (ΔG°’ −16.7), PFK-1 (−14.2) and pyruvate kinase (−31.4). Aldolase has ΔG°’ +23.8 kJ/mol but runs forward because its products are removed.
- GAPDH has an active-site Cys (thiohemiacetal, then thioester intermediate); it is inhibited by iodoacetate. Arsenate substitutes for Pᵢ, giving 1-arseno-3-phosphoglycerate that hydrolyses spontaneously, so step 7’s ATP is lost. Fluoride inhibits enolase.
- Regulation of PFK-1 (the key control point): inhibited by ATP (at an allosteric site) and citrate; activated by AMP, ADP and especially fructose 2,6-bisphosphate. Pyruvate kinase: activated by fructose 1,6-bisphosphate (feed-forward); liver isozyme inhibited by phosphorylation (glucagon) and by ATP and alanine.
Fates of pyruvate
| Condition | Product | Enzyme(s) | Purpose |
|---|---|---|---|
| Anaerobic muscle, RBC, lactic acid bacteria | Lactate | Lactate dehydrogenase | Regenerates NAD⁺ |
| Yeast (anaerobic) | Ethanol + CO₂ | Pyruvate decarboxylase (TPP), alcohol dehydrogenase | Regenerates NAD⁺ |
| Aerobic | Acetyl-CoA + CO₂ | Pyruvate dehydrogenase complex (mitochondria) | Feeds the TCA cycle |
| Gluconeogenesis, anaplerosis | Oxaloacetate | Pyruvate carboxylase (biotin) | Glucose synthesis, refilling the TCA cycle |
| Amino-acid synthesis | Alanine | Alanine aminotransferase | Glucose–alanine cycle |
Pyruvate dehydrogenase complex (PDH): E1 (pyruvate dehydrogenase, TPP), E2 (dihydrolipoyl transacetylase, lipoamide, CoA), E3 (dihydrolipoyl dehydrogenase, FAD, NAD⁺): five coenzymes, four from vitamins (thiamine, pantothenate, riboflavin, niacin). Regulation: product inhibition (acetyl-CoA, NADH) and phosphorylation by PDH kinase inactivates E1; PDH phosphatase (stimulated by Ca²⁺ and insulin) reactivates. Arsenite inhibits by binding the reduced lipoamide dithiol.
Gluconeogenesis
Synthesis of glucose from pyruvate, lactate, glycerol and glucogenic amino acids, mainly in liver (and kidney cortex). It uses the seven reversible glycolytic steps and bypasses the three irreversible ones:
| Glycolytic step bypassed | Gluconeogenic enzyme(s) | Location |
|---|---|---|
| Pyruvate kinase | Pyruvate carboxylase (biotin, ATP; activated by acetyl-CoA) then PEP carboxykinase (GTP) | Mitochondria, then cytosol (or mitochondria) |
| PFK-1 | Fructose 1,6-bisphosphatase-1 | Cytosol |
| Hexokinase | Glucose 6-phosphatase | ER lumen; liver and kidney, not muscle (so muscle glycogen cannot give blood glucose) |
Cost: 2 pyruvate → glucose uses 4 ATP + 2 GTP + 2 NADH, compared with 2 ATP gained in glycolysis.
Reciprocal regulation by fructose 2,6-bisphosphate: it activates PFK-1 and inhibits FBPase-1. It is made and destroyed by the bifunctional PFK-2/FBPase-2. In liver, glucagon → cAMP → PKA phosphorylates this enzyme, activating FBPase-2, so F2,6BP falls: glycolysis slows and gluconeogenesis rises. Insulin does the reverse.
Cori cycle: muscle lactate → liver glucose → muscle. Glucose–alanine cycle: muscle alanine carries both carbon and nitrogen to the liver.
The Pentose Phosphate Pathway
- Oxidative phase (irreversible): glucose 6-phosphate → 6-phosphogluconolactone (glucose 6-phosphate dehydrogenase, the rate-limiting step, makes NADPH) → 6-phosphogluconate → ribulose 5-phosphate + CO₂ (6-phosphogluconate dehydrogenase, second NADPH). Net: 2 NADPH and 1 CO₂ per G6P.
- Non-oxidative phase (reversible): transketolase (TPP; transfers 2-carbon units) and transaldolase (3-carbon units) interconvert pentoses with glycolytic intermediates.
- Uses: NADPH for fatty-acid and sterol synthesis and for glutathione reduction; ribose 5-phosphate for nucleotides.
- G6PD deficiency: red cells cannot keep glutathione reduced; oxidant drugs (primaquine) or fava beans trigger haemolysis.
Glycogen Metabolism
| Process | Key enzyme | Notes |
|---|---|---|
| Breakdown | Glycogen phosphorylase (PLP) | Phosphorolysis at α1→4 bonds, releasing glucose 1-phosphate (no ATP needed for the phosphorylation); stops 4 residues from a branch |
| Debranching | Debranching enzyme | Transferase moves 3 residues; α1→6 glucosidase releases one free glucose |
| Conversion | Phosphoglucomutase | G1P ⇌ G6P |
| Synthesis | UDP-glucose pyrophosphorylase, then glycogen synthase | Adds glucose from UDP-glucose to non-reducing ends (α1→4); PPᵢ hydrolysis drives UDP-glucose formation |
| Branching | Branching enzyme | Moves a 6–7 residue segment to an α1→6 position |
| Primer | Glycogenin | Self-glucosylates to start a new particle |
Regulation: glucagon (liver) or adrenaline (liver and muscle) → cAMP → PKA → phosphorylase kinase → phosphorylase b → a (active). PKA and GSK3 phosphorylate glycogen synthase, inactivating it. Insulin activates protein phosphatase 1 (PP1), reversing both. Muscle phosphorylase b is also activated allosterically by AMP and phosphorylase kinase by Ca²⁺; liver phosphorylase a is inhibited by glucose (a glucose sensor).
The Citric Acid (TCA, Krebs) Cycle
Location: mitochondrial matrix (succinate dehydrogenase in the inner membrane).
graph LR
AC["Acetyl-CoA"] --> CS["1 Citrate synthase"]
OAA["Oxaloacetate"] --> CS
CS --> CIT["Citrate"]
CIT -->|"2 Aconitase"| ICT["Isocitrate"]
ICT -->|"3 Isocitrate DH: NADH, CO2"| AKG["alpha-Ketoglutarate"]
AKG -->|"4 alpha-KG DH complex: NADH, CO2"| SCOA["Succinyl-CoA"]
SCOA -->|"5 Succinyl-CoA synthetase: GTP or ATP"| SUC["Succinate"]
SUC -->|"6 Succinate DH: FADH2"| FUM["Fumarate"]
FUM -->|"7 Fumarase"| MAL["Malate"]
MAL -->|"8 Malate DH: NADH"| OAAPer acetyl-CoA: 3 NADH, 1 FADH₂ (as enzyme-bound FADH₂ passing electrons to ubiquinone), 1 GTP or ATP, 2 CO₂. The two CO₂ released in one turn do not come from the carbons of the acetyl group that just entered.
- α-Ketoglutarate dehydrogenase complex is homologous to PDH (same five coenzymes; shares E3).
- Malate dehydrogenase has ΔG°’ +29.7 kJ/mol; it runs forward because citrate synthase keeps oxaloacetate very low.
- Inhibitors: malonate (competitive, succinate dehydrogenase); fluoroacetate is converted to fluorocitrate, which inhibits aconitase; arsenite blocks lipoamide in PDH and α-KGDH.
- Regulation: citrate synthase, isocitrate dehydrogenase and α-KGDH. Inhibited by high NADH, ATP, succinyl-CoA, citrate; isocitrate dehydrogenase activated by ADP; Ca²⁺ activates isocitrate dehydrogenase and α-KGDH (muscle contraction).
- Amphibolic: intermediates leave for biosynthesis (citrate → fatty acids; α-KG → glutamate; succinyl-CoA → haem; oxaloacetate → aspartate, glucose). Anaplerotic reactions refill them, chiefly pyruvate carboxylase.
- Glyoxylate cycle (plants, especially germinating oilseeds; bacteria; fungi): isocitrate lyase and malate synthase bypass the two decarboxylations, giving net synthesis of C4 compounds from acetyl-CoA, so fat can become glucose. Animals lack it and cannot make net glucose from even-chain fatty acids.
Oxidative Phosphorylation
The respiratory chain
| Complex | Name | Prosthetic groups | H⁺ pumped (per 2e⁻) | Inhibitors |
|---|---|---|---|---|
| I | NADH:ubiquinone oxidoreductase | FMN, Fe–S clusters | 4 | Rotenone, amytal, piericidin |
| II | Succinate dehydrogenase | FAD, Fe–S, haem b | 0 | Malonate (substrate site), carboxin |
| — | Ubiquinone (Q) | Lipid-soluble mobile carrier | — | — |
| III | Cytochrome bc₁ complex | Haems b, c₁, Rieske Fe–S | 4 (via the Q cycle) | Antimycin A, myxothiazol |
| — | Cytochrome c | Haem c; peripheral, IMS side | — | — |
| IV | Cytochrome oxidase | Cu_A, haem a, haem a₃–Cu_B | 2 (plus 2 H⁺ consumed making H₂O) | Cyanide, azide, CO, H₂S |
Totals: 10 H⁺ per NADH (I + III + IV) and 6 H⁺ per succinate (II + III + IV). Electron-transferring flavoprotein (fatty-acid oxidation) and glycerol 3-phosphate dehydrogenase also feed electrons to Q, bypassing complex I.
Chemiosmotic coupling
Mitchell’s chemiosmotic theory (1961): electron transfer pumps protons from the matrix to the intermembrane space, creating a proton-motive force (an electrical potential Δψ, matrix negative, plus a pH gradient ΔpH, matrix alkaline). Protons flow back through ATP synthase, driving ATP formation. The free energy per mole of H⁺ moved out is
$$\Delta G = 2.303RT\,\Delta\mathrm{pH} + F\Delta\psi$$Evidence: an intact, closed inner membrane is required; uncouplers (DNP, FCCP) are lipid-soluble weak acids that carry H⁺ back across the membrane, dissipating the gradient without stopping electron flow; Jagendorf’s acid-bath experiment showed that an artificially imposed pH gradient makes chloroplast thylakoids synthesise ATP in the dark; reconstituted vesicles with a light-driven proton pump and ATP synthase make ATP.
ATP synthase (F₀F₁)
- F₀ (membrane; c-ring) conducts protons; oligomycin binds F₀ and blocks proton flow. F₁ (α₃β₃γδε) synthesises ATP on the three β subunits.
- Binding-change mechanism (Boyer): each β subunit cycles through O (open), L (loose) and T (tight) states as the central γ subunit rotates. In the T site, ADP + Pᵢ ⇌ ATP is near equilibrium; the energy of the proton flow is used mainly to release tightly bound ATP. Rotation was seen directly by attaching a fluorescent actin filament to γ.
- With 8 c subunits (mammalian c-ring) a full rotation moves 8 H⁺ and makes 3 ATP (about 2.7 H⁺/ATP), plus about 1 H⁺ to import Pᵢ (phosphate translocase), giving the commonly used 4 H⁺ per ATP.
- Adenine nucleotide translocase exchanges matrix ATP⁴⁻ for cytosolic ADP³⁻ (driven by Δψ); inhibited by atractyloside and bongkrekic acid.
P/O ratios and the ATP yield of glucose
P/O = 10/4 = 2.5 for NADH and 6/4 = 1.5 for succinate (FADH₂).
Cytosolic NADH from glycolysis cannot cross the inner membrane. The malate–aspartate shuttle (liver, heart, kidney) delivers it as matrix NADH (2.5 ATP); the glycerol 3-phosphate shuttle (skeletal muscle, brain) delivers it to Q as FADH₂ (1.5 ATP).
| Source (per glucose) | ATP |
|---|---|
| Glycolysis: substrate level | 2 |
| Glycolysis: 2 cytosolic NADH | 3 (glycerol-P shuttle) or 5 (malate–Asp) |
| PDH: 2 NADH | 5 |
| TCA: 6 NADH | 15 |
| TCA: 2 FADH₂ | 3 |
| TCA: 2 GTP/ATP | 2 |
| Total | 30 or 32 |
Respiratory control and uncoupling
- Respiratory control: with coupled mitochondria, the rate of O₂ use is set by ADP availability (state 3 with ADP, state 4 when ADP is exhausted).
- Uncoupling protein 1 (thermogenin) in brown adipose tissue lets protons return without making ATP: heat production (non-shivering thermogenesis, newborns, hibernators).
Lipid Metabolism
Fatty-acid oxidation
- Activation in the cytosol: fatty acid + CoA + ATP → fatty acyl-CoA + AMP + PPᵢ (acyl-CoA synthetase). Costs 2 ATP equivalents.
- Transport into mitochondria by the carnitine shuttle: carnitine acyltransferase I (CPT-I, outer membrane) is inhibited by malonyl-CoA, the first intermediate of fatty-acid synthesis, so synthesis and oxidation do not run together.
- β-Oxidation, four steps per cycle: acyl-CoA dehydrogenase (FAD) → enoyl-CoA hydratase → β-hydroxyacyl-CoA dehydrogenase (NAD⁺) → thiolase (CoA). Each cycle removes one acetyl-CoA and yields 1 FADH₂ and 1 NADH.
Palmitate (16:0): 7 cycles give 8 acetyl-CoA, 7 FADH₂, 7 NADH. ATP = 8 × 10 + 7 × 1.5 + 7 × 2.5 − 2 = 80 + 10.5 + 17.5 − 2 = 106 ATP.
- Unsaturated fatty acids: cis-Δ³ bonds need enoyl-CoA isomerase; polyunsaturated ones also need 2,4-dienoyl-CoA reductase (NADPH).
- Odd-chain fatty acids end in propionyl-CoA → (propionyl-CoA carboxylase, biotin) D-methylmalonyl-CoA → epimerase → L-methylmalonyl-CoA → (methylmalonyl-CoA mutase, coenzyme B₁₂) succinyl-CoA, which is glucogenic.
- Peroxisomal β-oxidation shortens very-long-chain fatty acids; its first enzyme (acyl-CoA oxidase) passes electrons straight to O₂, forming H₂O₂ (no ATP from that step). Zellweger syndrome and X-linked adrenoleukodystrophy involve peroxisomal defects.
- α-Oxidation (peroxisomes) handles branched phytanic acid (Refsum disease); ω-oxidation (ER) oxidises the methyl end.
Ketone bodies
In the liver during fasting or uncontrolled diabetes, excess acetyl-CoA forms acetoacetate, D-β-hydroxybutyrate and (spontaneously) acetone, via mitochondrial HMG-CoA synthase and HMG-CoA lyase. Heart, muscle and (in prolonged fasting) brain use them, converting acetoacetate to acetoacetyl-CoA with succinyl-CoA:acetoacetate CoA transferase (thiophorase). The liver lacks this transferase, so it exports ketone bodies rather than using them.
Fatty-acid synthesis
- Acetyl-CoA leaves mitochondria as citrate (citrate lyase regenerates it in the cytosol).
- Acetyl-CoA carboxylase (ACC, biotin, ATP): acetyl-CoA → malonyl-CoA, the committed, rate-limiting step. Activated by citrate (polymerisation) and insulin; inhibited by palmitoyl-CoA and by phosphorylation (AMP-activated protein kinase, glucagon, adrenaline).
- Fatty acid synthase (in mammals one multifunctional polypeptide, working as a dimer) uses an acyl carrier protein (ACP) with a phosphopantetheine arm. Each cycle: condensation (releasing CO₂), reduction (NADPH), dehydration, reduction (NADPH).
- Palmitate: 8 acetyl-CoA + 7 ATP + 14 NADPH + 14 H⁺ → palmitate + 8 CoA + 7 ADP + 7 Pᵢ + 6 H₂O. NADPH from the pentose phosphate pathway and malic enzyme.
- Elongation (ER, mitochondria) and desaturation (Δ⁹ desaturase in mammals) give other fatty acids.
| Feature | β-Oxidation | Fatty-acid synthesis |
|---|---|---|
| Location | Mitochondria (and peroxisomes) | Cytosol |
| Acyl carrier | CoA | ACP |
| Electron carriers | FAD, NAD⁺ | NADPH |
| Hydroxyacyl isomer | L-β-hydroxyacyl | D-β-hydroxyacyl |
| Two-carbon unit | Acetyl-CoA released | Malonyl-CoA donates (with CO₂ loss) |
| Key control | CPT-I (malonyl-CoA inhibits) | Acetyl-CoA carboxylase |
Cholesterol synthesis
Acetyl-CoA → acetoacetyl-CoA → HMG-CoA (cytosolic HMG-CoA synthase) → mevalonate by HMG-CoA reductase (NADPH; the rate-limiting step, target of statins, regulated by sterol levels through SREBP, by phosphorylation via AMPK and by degradation) → activated isoprene units (isopentenyl pyrophosphate, C5) → geranyl pyrophosphate (C10) → farnesyl pyrophosphate (C15) → squalene (C30) → lanosterol → cholesterol (C27). The isoprenoid branch also yields dolichol, ubiquinone and prenyl groups for protein anchoring.
Amino-Acid Metabolism
Removing the nitrogen
- Transamination: aminotransferases (PLP, ping-pong) move the α-amino group to α-ketoglutarate, forming glutamate. ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are clinical liver-damage markers.
- Oxidative deamination: glutamate dehydrogenase (mitochondrial; uses NAD⁺ or NADP⁺) releases NH₄⁺; allosterically activated by ADP and inhibited by GTP.
- Transport of NH₃: as glutamine (glutamine synthetase) from most tissues; as alanine from muscle.
The urea cycle
graph TD
N["NH4+ + HCO3-"] -->|"CPS I, 2 ATP
mitochondria; N-acetylglutamate activates"| CP["Carbamoyl phosphate"]
CP -->|"Ornithine transcarbamoylase
mitochondria"| CIT["Citrulline"]
ORN["Ornithine"] --> CIT
CIT -->|"Argininosuccinate synthetase
cytosol; ATP to AMP + PPi; aspartate enters"| AS["Argininosuccinate"]
AS -->|"Argininosuccinase"| ARG["Arginine + fumarate"]
ARG -->|"Arginase"| U["Urea + ornithine"]
U --> ORN- The two N atoms of urea come from NH₄⁺ (via carbamoyl phosphate) and aspartate; the carbon from HCO₃⁻.
- Cost: 4 high-energy phosphate bonds per urea (2 ATP at CPS I, plus ATP → AMP + PPᵢ at argininosuccinate synthetase).
- N-acetylglutamate (made from acetyl-CoA and glutamate, stimulated by arginine) is the obligatory activator of CPS I.
- Fumarate links the urea cycle to the TCA cycle (the “aspartate–argininosuccinate shunt”).
- Organisms excrete nitrogen as ammonia (ammonotelic: most aquatic animals), urea (ureotelic: mammals) or uric acid (uricotelic: birds, reptiles).
Carbon skeletons and special products
- Glucogenic amino acids give pyruvate or TCA intermediates; ketogenic ones give acetyl-CoA or acetoacetyl-CoA. Leucine and lysine are exclusively ketogenic; Phe, Tyr, Trp, Ile and Thr are both.
- Essential amino acids for humans: His, Ile, Leu, Lys, Met, Phe, Thr, Trp, Val (arginine conditionally).
- Products: Tyr → DOPA → dopamine → noradrenaline → adrenaline, melanin, thyroid hormones; Trp → serotonin, melatonin, NAD⁺ (niacin); His → histamine; Glu → GABA (PLP decarboxylase); Arg → nitric oxide (NO synthase) and, with Gly and Met, creatine; Gly + succinyl-CoA → δ-aminolevulinate (ALA synthase, PLP) → haem; Met → S-adenosylmethionine (methyl donor).
- Inborn errors: phenylketonuria (phenylalanine hydroxylase or its cofactor tetrahydrobiopterin); alkaptonuria (homogentisate 1,2-dioxygenase); maple syrup urine disease (branched-chain α-keto acid dehydrogenase); albinism (tyrosinase); homocystinuria (cystathionine β-synthase).
Nucleotide Metabolism
Purines (built on the sugar)
- Start: ribose 5-phosphate + ATP → PRPP (ribose-phosphate pyrophosphokinase).
- Committed step: glutamine-PRPP amidotransferase → 5-phosphoribosylamine; feedback-inhibited by IMP, AMP and GMP.
- The ring is assembled on ribose phosphate; the first purine is IMP (inosinate).
- Atom sources: N1 from aspartate; C2 and C8 from N¹⁰-formyl-THF; N3 and N9 from glutamine (amide N); C4, C5 and N7 from glycine; C6 from CO₂ (HCO₃⁻).
- IMP → AMP (aspartate N, uses GTP); IMP → GMP (glutamine N, uses ATP). This cross-dependence balances the two pools.
- Salvage: HGPRT (hypoxanthine, guanine + PRPP) and APRT. HGPRT deficiency causes Lesch–Nyhan syndrome.
- Degradation: AMP → IMP → inosine → hypoxanthine → xanthine → uric acid (xanthine oxidase; inhibited by allopurinol in gout). Adenosine deaminase (ADA) deficiency causes a form of SCID (toxic dATP accumulates in lymphocytes).
Pyrimidines (ring first, then sugar)
- Carbamoyl phosphate synthetase II (cytosol; uses glutamine, not NH₄⁺) → carbamoyl phosphate.
- Aspartate transcarbamoylase → carbamoyl aspartate → (dihydroorotase) dihydroorotate → (dihydroorotate dehydrogenase, on the inner mitochondrial membrane, passing electrons to ubiquinone) orotate → + PRPP → OMP → (decarboxylase) UMP.
- In bacteria, ATCase is the regulated step (CTP inhibits, ATP activates). In animals, CPS II is regulated (UTP inhibits, PRPP activates), and the first three enzymes are one multifunctional protein (CAD).
- Atom sources: N3 and C2 from carbamoyl phosphate (N from Gln, C from HCO₃⁻); N1, C4, C5, C6 from aspartate.
- UMP → UDP → UTP → CTP (CTP synthetase, Gln amide).
- Orotic aciduria: defect in the bifunctional UMP synthase (OPRTase and OMP decarboxylase).
Deoxyribonucleotides and thymidylate
- Ribonucleotide reductase reduces NDPs to dNDPs, using electrons from NADPH via thioredoxin (or glutaredoxin); class I enzymes use a tyrosyl radical. Two allosteric sites: the activity site (ATP activates, dATP inhibits the whole enzyme) and the specificity site (selects which substrate is reduced). Hydroxyurea quenches the radical.
- Thymidylate synthase: dUMP + N⁵,N¹⁰-methylene-THF → dTMP + DHF. Dihydrofolate reductase regenerates THF. Cancer drugs: 5-fluorouracil (FdUMP, suicide inhibitor of thymidylate synthase), methotrexate (DHFR); trimethoprim (bacterial DHFR).
Coenzymes across metabolism
| Coenzyme (vitamin) | Where you meet it on this page |
|---|---|
| TPP (B₁) | PDH, α-KGDH, transketolase, pyruvate decarboxylase |
| FAD (B₂) | Succinate DH, acyl-CoA DH, PDH E3 |
| NAD⁺/NADP⁺ (B₃) | Dehydrogenases; NADPH in PPP, fatty acid and sterol synthesis |
| CoA (B₅) | Acetyl-CoA, succinyl-CoA, β-oxidation |
| PLP (B₆) | Aminotransferases, glycogen phosphorylase, ALA synthase, decarboxylases |
| Biotin (B₇) | Pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase |
| THF (B₉) | Purine C2, C8; thymidylate synthesis |
| Cobalamin (B₁₂) | Methylmalonyl-CoA mutase, methionine synthase |
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Substrate-level phosphorylation (PGK, PK, succinyl-CoA synthetase) | vs | Oxidative phosphorylation (ATP synthase, proton gradient) |
| CPS I: mitochondria, NH₄⁺, urea cycle, N-acetylglutamate | vs | CPS II: cytosol, glutamine, pyrimidines |
| Phosphorolysis (phosphorylase → G1P) | vs | Hydrolysis (debranching α1→6 → free glucose) |
| Malate–aspartate shuttle: 2.5 ATP per cytosolic NADH | vs | Glycerol 3-phosphate shuttle: 1.5 ATP |
| Oligomycin: blocks ATP synthase; O₂ use falls | vs | DNP: uncoupler; O₂ use rises, ATP falls |
| Purines: built on PRPP | vs | Pyrimidines: ring first, then PRPP |
| F2,6BP (regulator, made by PFK-2) | vs | F1,6BP (glycolytic intermediate, made by PFK-1) |
| Pyruvate carboxylase: biotin, mitochondria | vs | PEP carboxykinase: GTP, no biotin |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which three glycolytic enzymes catalyse irreversible steps?
- Name the inhibitor of complex III used in respiration experiments.
- Which enzyme catalyses the rate-limiting step of cholesterol synthesis?
Answers
- Hexokinase, phosphofructokinase-1, pyruvate kinase.
- Antimycin A.
- HMG-CoA reductase.
Level 2: Part B Style
Q1 (practice). Under standard conditions, which reaction is thermodynamically favourable?
- (a) ATP + creatine → ADP + phosphocreatine
- (b) Glucose 6-phosphate + ADP → glucose + ATP
- (c) PEP + ADP → pyruvate + ATP
- (d) Glycerol 3-phosphate + ADP → glycerol + ATP
Answer and explanation
(c). ΔG°’ = −61.9 + 30.5 = −31.4 kJ/mol. For (a), +43.0 − 30.5 = +12.5 kJ/mol (the reverse, phosphocreatine → ATP, is favourable). (b) and (d) transfer from compounds with lower group-transfer potential than ATP, so ΔG°’ is positive.
Q2 (practice). Oxidation of one molecule of stearate (18:0) to CO₂ and H₂O yields how many ATP (P/O 2.5 for NADH, 1.5 for FADH₂)?
- (a) 106
- (b) 120
- (c) 122
- (d) 129
Answer and explanation
(b) 120. 8 cycles of β-oxidation → 9 acetyl-CoA, 8 FADH₂, 8 NADH. 9 × 10 + 8 × 1.5 + 8 × 2.5 = 90 + 12 + 20 = 122; subtract 2 for activation (ATP → AMP) = 120. (122 forgets activation; 106 is palmitate.)
Q3 (practice). A child has hyperammonaemia and greatly elevated plasma citrulline, with low arginine. The most likely deficient enzyme is:
- (a) Carbamoyl phosphate synthetase I
- (b) Ornithine transcarbamoylase
- (c) Argininosuccinate synthetase
- (d) Arginase
Answer and explanation
(c). Citrulline accumulates when the step that consumes it (condensation with aspartate) fails. Defects at CPS I or OTC would give low citrulline; arginase deficiency raises arginine.
Q4 (practice). In the de novo purine pathway, the atoms N3 and N9 come from:
- (a) Aspartate
- (b) Glycine
- (c) The amide nitrogen of glutamine
- (d) N¹⁰-formyl-tetrahydrofolate
Answer and explanation
(c). N3 and N9: glutamine; N1: aspartate; C4, C5, N7: glycine; C2, C8: formyl-THF; C6: CO₂.
Level 3: Part C Style
Q1 (practice). In a cell at 37 °C, [ATP] = 5.0 mM, [ADP] = 0.50 mM and [Pᵢ] = 5.0 mM. (i) Calculate the actual ΔG for ATP hydrolysis (ΔG°’ = −30.5 kJ/mol). (ii) Calculate ΔG°’ for transfer of a pair of electrons from NADH to O₂ and from succinate to O₂. (iii) If the proton-motive force has ΔpH = 0.75 and Δψ = 0.17 V, what is the free energy for moving 1 mol of H⁺ out, and is 4 H⁺ per ATP thermodynamically sufficient?
Answer and worked solution
- \(Q = \dfrac{[\mathrm{ADP}][\mathrm{P_i}]}{[\mathrm{ATP}]} = \dfrac{(0.5\times10^{-3})(5\times10^{-3})}{5\times10^{-3}} = 5\times10^{-4}\). \(\Delta G = -30.5 + (8.314\times10^{-3})(310.15)\ln(5\times10^{-4}) = -30.5 + 2.579(-7.60) = -30.5 - 19.6 = \mathbf{-50.1}\) kJ/mol. So synthesis needs about +50 kJ/mol.
- NADH → O₂: ΔE°’ = 0.816 − (−0.320) = 1.136 V; ΔG°’ = −2 × 96.485 × 1.136 = −219 kJ/mol. Succinate → O₂: ΔE°’ = 0.816 − 0.031 = 0.785 V; ΔG°’ = −151 kJ/mol.
- ΔG = 2.303 × 8.314 × 310 × 0.75 / 1000 + 96.485 × 0.17 = 4.45 + 16.4 = 20.9 kJ/mol of H⁺. Four protons provide about 83 kJ/mol, comfortably more than the ~50 kJ/mol needed to make ATP under these conditions; three would provide about 63 kJ/mol, also sufficient here, consistent with an H⁺/ATP stoichiometry of about 3 at the synthase plus 1 for transport.
Q2 (practice). Isolated liver mitochondria are suspended in buffer with Pᵢ in an oxygen electrode. The following additions are made in order: (1) β-hydroxybutyrate; (2) ADP; (3) rotenone; (4) succinate; (5) oligomycin; (6) DNP; (7) antimycin A; (8) ascorbate + TMPD; (9) KCN. Predict whether O₂ consumption increases, decreases or stays low after each, and explain steps 3, 4 and 8.
Answer and worked solution
| Addition | O₂ consumption | Reason |
|---|---|---|
| 1 β-Hydroxybutyrate | Slow | NADH-linked substrate, but no ADP (state 4) |
| 2 ADP | Increases | State 3: ATP synthase uses the gradient |
| 3 Rotenone | Stops | Complex I blocked; NADH electrons cannot reach Q |
| 4 Succinate | Resumes | Electrons enter at complex II → Q, bypassing complex I |
| 5 Oligomycin | Decreases | ATP synthase blocked; gradient builds, slowing electron flow (respiratory control) |
| 6 DNP | Increases sharply | Uncoupler dissipates the gradient; no ATP made |
| 7 Antimycin A | Stops | Complex III blocked |
| 8 Ascorbate + TMPD | Resumes | TMPD (reduced by ascorbate) donates electrons to cytochrome c, bypassing complex III |
| 9 KCN | Stops | Complex IV blocked; nothing downstream to bypass |
The logic tested: electrons can enter the chain at different points (NADH → I, succinate → II, artificial donors → cyt c), but nothing bypasses complex IV, and coupling means O₂ use depends on ADP unless an uncoupler is present.
Q3 (practice). Glucose labelled with ¹⁴C at different carbons is fed to (i) yeast fermenting anaerobically, and (ii) liver cells metabolising glucose by glycolysis and PDH. Which statements are correct?
(A) [3,4-¹⁴C]glucose releases its label as CO₂ in yeast during ethanol formation. (B) [1-¹⁴C]glucose labels the methyl carbon of pyruvate. (C) [1-¹⁴C]glucose oxidised through the oxidative pentose phosphate pathway releases its label as CO₂ at 6-phosphogluconate dehydrogenase. (D) [6-¹⁴C]glucose labels the carboxyl carbon of pyruvate.
- (a) A, B and C
- (b) A and D only
- (c) B and D only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C.
- Aldolase splits fructose 1,6-bisphosphate between C3 and C4. C1–C3 form DHAP, which triose phosphate isomerase converts to glyceraldehyde 3-phosphate with C3 of glucose becoming the aldehyde carbon (C1) and C1 becoming the phosphorylated carbon (C3). C4–C6 form glyceraldehyde 3-phosphate directly (C4 → C1, C6 → C3).
- So in pyruvate: C1 (carboxyl) ← glucose C3 and C4; C2 (carbonyl) ← C2 and C5; C3 (methyl) ← C1 and C6.
- (A) correct: pyruvate decarboxylase removes the carboxyl as CO₂. (B) correct. (D) wrong: C6 → methyl, not carboxyl.
- (C) correct: 6-phosphogluconate dehydrogenase removes C1 of glucose as CO₂. This is why the ratio of ¹⁴CO₂ from [1-¹⁴C] versus [6-¹⁴C]glucose is used to estimate pentose phosphate pathway activity.
Quick Revision Table
| Item | Fact |
|---|---|
| ATP → ADP + Pᵢ | ΔG°’ −30.5 kJ/mol; in cells about −50 to −65 |
| Above ATP | PEP −61.9, 1,3-BPG −49.3, PCr −43.0 |
| NADH → O₂ | ΔE°’ 1.136 V; ΔG°’ −219 kJ/mol |
| Glycolysis net | 2 ATP, 2 NADH, 2 pyruvate |
| Irreversible glycolytic steps | Hexokinase, PFK-1, pyruvate kinase |
| PFK-1 | − ATP, citrate; + AMP, F2,6BP |
| Gluconeogenesis bypasses | Pyruvate carboxylase + PEPCK; FBPase-1; G6Pase |
| PDH coenzymes | TPP, lipoamide, CoA, FAD, NAD⁺; kinase inactivates |
| TCA per acetyl-CoA | 3 NADH, 1 FADH₂, 1 GTP, 2 CO₂ |
| H⁺ pumped | I 4, III 4, IV 2; 10 per NADH, 6 per succinate |
| H⁺ per ATP / P/O | 4 / 2.5 (NADH), 1.5 (FADH₂) |
| Glucose yield | 30 or 32 ATP |
| Inhibitors | Rotenone I, malonate II, antimycin III, CN⁻/CO/azide IV, oligomycin F₀, atractyloside ANT |
| Palmitate | 106 ATP; synthesis needs 7 ATP + 14 NADPH |
| CPT-I | Inhibited by malonyl-CoA |
| ACC / HMG-CoA reductase | Fatty acid / cholesterol rate-limiting steps |
| Urea cycle | CPS I (NAG), OTC, ASS, ASL, arginase; 4 ~P per urea |
| Purely ketogenic | Leu, Lys |
| Purine atoms | N1 Asp; C2, C8 formyl-THF; N3, N9 Gln; C4, C5, N7 Gly; C6 CO₂ |
| Pyrimidine atoms | N3, C2 carbamoyl-P; N1, C4–C6 Asp |
| RNR | NDP → dNDP; dATP inhibits; thioredoxin; Tyr radical |
Key Takeaways
What’s Next
- Quick Revision — the whole unit on one page.
- Enzymes: Catalysis, Kinetics and Regulation — revisit allostery and covalent control with these pathways in mind.
- Structure and Function of Biomolecules — the chapter map.
- Life Sciences & Biotechnology — the full 14-unit syllabus and how this unit feeds the others.